Menopause
📧 Sign up to get email alerts when something new happens for Menopause.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Bioenergetic Effects of Aging and Menopause (BEAM) [Phase 4]
Phase 4 clinical trial update on bioenergetic effects of aging and menopause (BEAM) investigating menopause- and obesity-related outcomes.
-
FDA approval · 2023-11-20FDA Approved: LYLLANA — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for LYLLANA (estradiol) from Amneal Pharmaceuticals LLC (ANDA 211396).
-
FDA approval · 2023-11-14FDA Approved: ESTRADIOL — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved an Estradiol generic product from Padagis Israel Pharmaceuticals Ltd under an Original Application, enabling its use for estrog…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: RCT on the Treatment of Menopausal Syndrome With Chinese Medicine [Phase 2]
A Phase 2 randomized clinical trial update evaluating Chinese medicine for menopausal syndrome.
-
FDA approval · 2023-10-02FDA Approved: ANGELIQ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Angeliq (drospi renone and estradiol) from Bayer, updating labeling for postmenopausal indicatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-06FDA Approved: ESTRADIOL — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for a generic Estradiol product.
-
FDA approval · 2023-08-24FDA Approved: ESTRADIOL — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's Estradiol as an original-application generic product (ANDA217610).
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes [Phase 2]
A Phase 2 trial evaluating ESN364 in early postmenopausal women with hot flashes has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: HIRREM Hot Flashes Study [NA]
Clinical trial update for the HIRREM hot flashes study shows completed status with posted results.
-
FDA approval · 2023-04-28FDA Approved: ESTRADIOL VALERATE — Original Application (Xiromed, LLC)
The FDA approved Xiromed, LLC's Estradiol Valerate as an original-application generic (ANDA 216656), authorizing its marketing for approved …
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms [Phase 2]
Phase 2 trial of BAY3427080 (NT-814) in moderate to severe post-menopausal vasomotor symptoms completed with results posted in 2023.
-
CLINICAL_TRIALS research · 2023-02-22Clinical Trial Update: Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes [NA]
Clinical trial update on behavioral treatment for menopausal insomnia with sleep and daytime outcomes; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health [Phase 2]
Phase 2 trial assessing a novel probiotic supplement for menopausal symptoms and bone health has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause [Phase 3]
Phase 3 long-term safety trial of fezolinetant for menopausal hot flashes has completed and posted results on February 1, 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Bone Health in Aging HIV Infected Women [Phase 4]
This Phase 4 clinical trial update reports completion and results posting of a study on bone health in aging women with HIV, focusing on ost…
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: The Menopause After Cancer Study [Phase 2]
Phase 2 clinical trial update for the Menopause After Cancer Study completed, investigating menopause-related symptoms in cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Effects of Xiangshao Granules on Anxiety in Menopausal Women. [Phase 4]
Phase 4 trial update investigating Xiangshao Granules for anxiety in menopausal women.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms [Phase 2]
Phase 2 long-term safety and efficacy study of MT-8554 for vasomotor symptoms in postmenopausal women has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause [Phase 3]
Phase 3 trial evaluating fezolinetant for reducing hot flashes in menopausal women has completed and posted results in 2022.
-
FDA approval · 2022-08-10FDA Approved: ESTRADIOL — Original Application (Xiromed, LLC)
FDA approved Xiromed, LLC's Estradiol Gel 0.1% as an original application (ANDA) for generic estradiol gel.
-
CLINICAL_TRIALS withdrawal · 2022-07-20Clinical Trial Update: Testosterone Effects on Pelvic Floor Muscles [Phase 3]
A Phase 3 clinical trial investigating testosterone effects on pelvic floor muscles for urinary incontinence and menopause has been withdraw…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Reducing the Experience of Menopausal Symptoms Through Temperature [NA]
A completed clinical trial investigating the reduction of menopausal hot flashes using a temperature-based intervention; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2 [Phase 3]
Phase 3 trial results for fezolinetant evaluating reduction of moderate to severe hot flashes in menopausal women; sponsor-reported results …
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Progesterone and Resting Energy Expenditure [Phase 4]
Phase 4 trial update for progesterone related to resting energy expenditure in menopause; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®) [Phase 4]
Phase 4 trial comparing tibolone with continuous combined low-dose estradiol/norethindrone in menopause patients has completed.